the Effect of Isosorbide Mononitrate in Reducing Pain During Cooper Intrauterine Device Insertion
NCT ID: NCT04312048
Last Updated: 2021-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
110 participants
INTERVENTIONAL
2020-04-15
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD.
NCT03499743
Efficacy of Ketoprofen Before Intrauterine Device Insertion
NCT02905058
The Analgesic Efficacy of Forced Coughing During Intrauterine Device Insertion
NCT04602897
Different Analgesics Prior to Intrauterine Device (IUD) Insertion: Is There Any Evidence?
NCT02522130
Multi-dose Ibuprofen Prophylaxis for IUD-insertion
NCT03868137
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Isosorbide Mononitrate
one tablet of Isosorbide Mononitrate (40 mg) vaginally 3 hours prior to copper IUD insertion
Isosorbide mononitrate
one tablet of Isosorbide Mononitrate (40 mg) vaginally 3 hours prior to copper IUD insertion
placebo
one tablet of placebo vaginally 3 hours prior to copper IUD insertion
placebo
one tablet of placebo vaginally 3 hours prior to copper IUD insertion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Isosorbide mononitrate
one tablet of Isosorbide Mononitrate (40 mg) vaginally 3 hours prior to copper IUD insertion
placebo
one tablet of placebo vaginally 3 hours prior to copper IUD insertion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Samy aly ashour
assistant professor obstetrics and gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahmoud alalfy, MD
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed Samy
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00249
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.